Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfried Kohlschütter

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Handbook of Clinical Neurology|April 30, 2013
Lysosomal leukodystrophies: Krabbe disease and metachromatic leukodystrophyAlfried Kohlschütter
Frontiers in Neurology|July 12, 2021
Ethical Issues in Care and Treatment of Neuronal Ceroid Lipofuscinoses (NCL)-A Personal ViewAlfried Kohlschütter
Expert Review of Neurotherapeutics|September 30, 2011
Childhood leukodystrophies: a clinical perspectiveAlfried Kohlschütter, Florian Eichler
Brain & Development|February 7, 2009
Towards understanding the neuronal ceroid lipofuscinosesAlfried Kohlschütter, Angela Schulz
Iranian Journal of Child Neurology|March 26, 2014
NCL Disorders: Frequent Causes of Childhood DementiaAngela Schulz, Alfried Kohlschütter
Pediatric Endocrinology Reviews : PER|August 6, 2016
CLN2 Disease (Classic Late Infantile Neuronal Ceroid Lipofuscinosis)Alfried Kohlschütter, Angela Schulz
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|March 18, 2019
[Early diagnosis of a rare disease in children through better communication between parents, physicians and academic centers]Alfried Kohlschütter, Hendrik van den Bussche
Free Radical Research|May 16, 2003
Membrane oxidation assay--a novel lipoxygenase-based evaluation of membrane oxidizabilityZoltan Lukacs, Jutta Gieseking, Barbara Finckh, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 11, 2004
Effects of the ketogenic diet in the glucose transporter 1 deficiency syndromeJörg Klepper, Sonja Diefenbach, Alfried Kohlschütter, et al.
CNS Drugs|March 17, 2019
Current and Emerging Treatment Strategies for Neuronal Ceroid LipofuscinosesAlfried Kohlschütter, Angela Schulz, Udo Bartsch, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Handbook of Clinical Neurology|April 30, 2013
Lysosomal leukodystrophies: Krabbe disease and metachromatic leukodystrophyAlfried Kohlschütter
Frontiers in Neurology|July 12, 2021
Ethical Issues in Care and Treatment of Neuronal Ceroid Lipofuscinoses (NCL)-A Personal ViewAlfried Kohlschütter
Expert Review of Neurotherapeutics|September 30, 2011
Childhood leukodystrophies: a clinical perspectiveAlfried Kohlschütter, Florian Eichler
Brain & Development|February 7, 2009
Towards understanding the neuronal ceroid lipofuscinosesAlfried Kohlschütter, Angela Schulz
Iranian Journal of Child Neurology|March 26, 2014
NCL Disorders: Frequent Causes of Childhood DementiaAngela Schulz, Alfried Kohlschütter
Pediatric Endocrinology Reviews : PER|August 6, 2016
CLN2 Disease (Classic Late Infantile Neuronal Ceroid Lipofuscinosis)Alfried Kohlschütter, Angela Schulz
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|March 18, 2019
[Early diagnosis of a rare disease in children through better communication between parents, physicians and academic centers]Alfried Kohlschütter, Hendrik van den Bussche
Free Radical Research|May 16, 2003
Membrane oxidation assay--a novel lipoxygenase-based evaluation of membrane oxidizabilityZoltan Lukacs, Jutta Gieseking, Barbara Finckh, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 11, 2004
Effects of the ketogenic diet in the glucose transporter 1 deficiency syndromeJörg Klepper, Sonja Diefenbach, Alfried Kohlschütter, et al.
CNS Drugs|March 17, 2019
Current and Emerging Treatment Strategies for Neuronal Ceroid LipofuscinosesAlfried Kohlschütter, Angela Schulz, Udo Bartsch, et al.
Pageof 7